Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oregon CBD is a privately held hemp genetics and cannabis breeding company focused on research, development, and commercialization of feminized hemp seed varieties for farmers. The company operates as a federally compliant cannabis R&D business under the 2018 Farm Bill and markets high-cannabinoid seed genetics spanning CBD, CBG, CBDV, CBGV, and autoflower lines. Its core differentiators are in-house breeding, genomic mapping, advanced ploidy screening, and commercialization of triploid seedless hemp varieties. Rather than developing human therapeutics, Oregon CBD serves the agricultural and cannabinoid supply chain by supplying organic-certified and non-GMO hemp seeds optimized for compliant cultivation, flower, and biomass production. The company appears to be an active, independent business associated with Jack Hempicine and based in Oregon's Willamette Valley.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oregon CBD.